These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 2524586)
1. In vivo metabolism of atrial natriuretic peptide: identification of plasma metabolites and enzymes responsible for their generation. Krieter PA; Olins GM; Verrett SP; Durley RC J Pharmacol Exp Ther; 1989 May; 249(2):411-7. PubMed ID: 2524586 [TBL] [Abstract][Full Text] [Related]
2. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide. Tamburini PP; Koehn JA; Gilligan JP; Charles D; Palmesino RA; Sharif R; McMartin C; Erion MD; Miller MJ J Pharmacol Exp Ther; 1989 Dec; 251(3):956-61. PubMed ID: 2532252 [TBL] [Abstract][Full Text] [Related]
3. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit. Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398 [TBL] [Abstract][Full Text] [Related]
4. Characterization of atrial natriuretic peptide degradation by cell-surface peptidase activity on endothelial cells. Frost SJ; Whitson PA J Cell Biochem; 1993 Jun; 52(2):227-36. PubMed ID: 8366138 [TBL] [Abstract][Full Text] [Related]
5. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. Bauer WR; Neubauer S; Obitz G; Ertl G J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008 [TBL] [Abstract][Full Text] [Related]
8. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. Wegner M; Hirth-Dietrich C; Stasch JP Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity. Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney. Brier ME; Harding GB J Pharmacol Exp Ther; 1989 May; 249(2):372-7. PubMed ID: 2542527 [TBL] [Abstract][Full Text] [Related]
14. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related]
15. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat. Zukowska-Grojec Z; Haass M; Kopin IJ; Zamir N J Pharmacol Exp Ther; 1986 Nov; 239(2):480-7. PubMed ID: 2877083 [TBL] [Abstract][Full Text] [Related]
16. Clearance receptors for atrial natriuretic petide in Milan hypertensive and normotensive rats. Aptel HB; Wannop DW; al-Busada K; Henderson IW J Hypertens; 1996 Apr; 14(4):461-8. PubMed ID: 8761895 [TBL] [Abstract][Full Text] [Related]
17. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo. Olins GM; Krieter PA; Trapani AJ; Spear KL; Bovy PR Mol Cell Endocrinol; 1989 Feb; 61(2):201-8. PubMed ID: 2521834 [TBL] [Abstract][Full Text] [Related]
18. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B. Thibault G; Grove KL; Deschepper CF Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004 [TBL] [Abstract][Full Text] [Related]
19. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats. Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815 [TBL] [Abstract][Full Text] [Related]
20. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading. Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]